| YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis R Gao, RKR Kalathur, M Coto‐Llerena, C Ercan, D Buechel, S Shuang, ... EMBO molecular medicine 13 (12), e14351, 2021 | 337 | 2021 |
| Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages CKY Ng, E Dazert, T Boldanova, M Coto-Llerena, S Nuciforo, C Ercan, ... Nature communications 13 (1), 2436, 2022 | 93 | 2022 |
| Arginine reprograms metabolism in liver cancer via RBM39 D Mossmann, C Müller, S Park, B Ryback, M Colombi, N Ritter, ... Cell 186 (23), 5068-5083. e23, 2023 | 87 | 2023 |
| High expression of FAP in colorectal cancer is associated with angiogenesis and immunoregulation processes M Coto-Llerena, C Ercan, V Kancherla, S Taha-Mehlitz, ... Frontiers in oncology 10, 979, 2020 | 78 | 2020 |
| Bipotent transitional liver progenitor cells contribute to liver regeneration W Pu, H Zhu, M Zhang, M Pikiolek, C Ercan, J Li, X Huang, X Han, ... Nature genetics 55 (4), 651-664, 2023 | 54 | 2023 |
| USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis R Gao, D Buechel, RKR Kalathur, MF Morini, M Coto-Llerena, C Ercan, ... Oncogenesis 10 (7), 52, 2021 | 45 | 2021 |
| Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis S Taha-Mehlitz, G Bianco, M Coto-Llerena, V Kancherla, GR Bantug, ... Theranostics 11 (9), 4011, 2021 | 33 | 2021 |
| GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers G Bianco, M Coto-Llerena, J Gallon, V Kancherla, S Taha-Mehlitz, ... Communications biology 5 (1), 373, 2022 | 18 | 2022 |
| Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo‐Independent Regulation of Heat Shock Protein 70 Family Members M Coto‐Llerena, N Tosti, S Taha‐Mehlitz, V Kancherla, V Paradiso, ... Hepatology communications 5 (4), 661-674, 2021 | 16 | 2021 |
| YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis. EMBO Mol. Med. 13, e14351 R Gao, RKR Kalathur, M Coto-Llerena, C Ercan, D Buechel, S Shuang, ... | 16 | 2021 |
| Characterization of HOXB13 expression patterns in localized and metastatic castration‐resistant prostate cancer RA Patel, E Sayar, I Coleman, MP Roudier, B Hanratty, JY Low, N Jaiswal, ... The Journal of Pathology 262 (1), 105-120, 2024 | 15 | 2024 |
| Transposon-activated POU5F1B promotes colorectal cancer growth and metastasis L Simó-Riudalbas, S Offner, E Planet, J Duc, L Abrami, S Dind, A Coudray, ... Nature Communications 13 (1), 4913, 2022 | 15 | 2022 |
| mTOR signaling mediates ILC3-driven immunopathology C Teufel, E Horvath, A Peter, C Ercan, S Piscuoglio, MN Hall, D Finke, ... Mucosal Immunology 14 (6), 1323-1334, 2021 | 15 | 2021 |
| Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report MA Meier, S Nuciforo, M Coto-Llerena, J Gallon, MS Matter, C Ercan, ... Communications Medicine 2 (1), 80, 2022 | 14 | 2022 |
| A Pygopus 2-Histone interaction is critical for cancer cell dedifferentiation and progression in malignant breast cancer M Saxena, RKR Kalathur, N Rubinstein, A Vettiger, N Sugiyama, ... Cancer research 80 (17), 3631-3648, 2020 | 13 | 2020 |
| AXL expression on homeostatic resident liver macrophages is reduced in cirrhosis following GAS6 production by hepatic stellate cells OT Pop, A Geng, E Flint, A Singanayagam, C Ercan, L Possamai, ... Cellular and molecular gastroenterology and hepatology 16 (1), 17-37, 2023 | 11 | 2023 |
| Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseq G Restivo, A Tastanova, Z Balázs, F Panebianco, M Diepenbruck, ... Communications Biology 5 (1), 1144, 2022 | 9 | 2022 |
| Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization T Boldanova, G Fucile, J Vosshenrich, A Suslov, C Ercan, M Coto-Llerena, ... Cell Reports Medicine 2 (11), 2021 | 9 | 2021 |
| Programmed death ligand‐1 expression levels, clinicopathologic features, and survival in surgically resected sarcomatoid lung carcinoma Y Ağaçkıran, F Aksu, N Akyürek, C Ercan, M Demiröz, K Aksu Asia‐Pacific Journal of Clinical Oncology 17 (3), 280-288, 2021 | 9 | 2021 |
| Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma J Gallon, M Coto‐Llerena, C Ercan, G Bianco, V Paradiso, S Nuciforo, ... Molecular oncology 16 (3), 665-682, 2022 | 7 | 2022 |
Savas SoysalProfessor für Chirurgie, Chirurgie im Zentrum, BaselVerified email at unibas.ch
